Emerging drugs for biliary cancer.

Emerging drugs for biliary cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Emerging drugs for biliary cancer. Abstract Text:

Florian Eckel,Roland M Schmid,Florian Eckel,Roland M Schmid,

Biliary cancer comprise carcinoma of the gallbladder as well as the intrahepatic, hilar and extrahepatic bile ducts. Furthermore, many different etiologies and risk factors are contributing to the inhomogeneity of this disease. It is often diagnosed at an advanced stage when potentially curative resection is not feasible. Due to the lack of randomised Phase III studies, there is no standard regimen for chemotherapy in biliary cancer. Recent investigations into the underlying molecular mechanisms involved in biliary carcinogenesis and tumour growth have contributed greatly to our understanding of biliary cancer. Through a better understanding of these mechanisms, improved and more specific diagnostic, therapeutic and preventive strategies may be developed. Although fluoropyrimidines and gemcitabine remain the backbone of routine chemotherapy in advanced disease, new agents such as epidermal growth factor receptor blockers and angiogenesis inhibitors may hold promise for improving the outcome for patients with biliary cancer.

Emerging drugs for biliary cancer. Publishing Authors By Initials

F Eckel,RM Schmid,F Eckel,RM Schmid,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Emerging drugs for biliary cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Expert opinion on emerging drugs

VOLUME: 12

Page Numbers: 571-89

Journal Abbreviation:

ISSN: 1744-7623

DAY: 5

MONTH: Nov

YEAR: 2007

Emerging drugs for biliary cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101135662

Emerging drugs for biliary cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Emerging drugs for biliary cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Emerging drugs for biliary cancer.

AFFILIATION: Technical University of Munich, Department of Internal Medicine, Klinikum rechts der Isar, Ismaninger Strasse 22, 81675 Munich, Germany. florian.eckel@lrz.tum.de

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Expert Opin Emerg Drugs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Emerging drugs for biliary cancer Related Publications

• A conformational unfolding reaction activates phage fd for the infection of Escherichia coli.
• Carbon metabolism and product inhibition determine the epoxidation efficiency of solvent-tolerant Pseudomonas sp. strain VLB120DeltaC.
• Cerebral near-infrared spectroscopy in adult patients after cardiac surgery is not useful for monitoring absolute values but may reflect trends in venous oxygenation under clinical conditions.
• Characterization of the C-terminal ER membrane anchor of PTP1B.
• Characterization of the genotoxic potential of formaldehyde in V79 cells.
• Clinical observations of sertindole in 53 hospitalised patients with psychotic disorders.
• Clinical validation of a digital transcutaneous PCO2/SpO2 ear sensor in adult patients after cardiac surgery.
• Coarse-grained lattice model for investigating the role of cooperativity in molecular recognition.
• Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method.
• Disorder-induced static antiferromagnetism in cuprate superconductors.
• Emerging drugs for biliary cancer.
• Emphysema and secondary pneumothorax in young adults smoking cannabis.
• Examples of Cross-Section Research on the Effect of the Built Environment on Physical Activity in Diverse Urban Communities: 246: 4:10 PM-4:35 PM.
• Groups of adjacent contour segments for object detection.
• Identification of a new porin, RafY, encoded by raffinose plasmid pRSD2 of Escherichia coli.
• Impact of the SMAS on Frey's syndrome after parotid surgery: a prospective, long-term study.
• Influence of comorbidity on outcome after pulmonary resection in the elderly.
• Inhibition of farnesyl protein transferase sensitizes human MCF-7 breast cancer cells to roscovitine-mediated cell cycle arrest.
• Interplay Between the p53 Tumor Suppressor Protein Family and Cdk5: Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases Using Selective Cdk Inhibitors.
• Microbial biofilms: new catalysts for maximizing productivity of long-term biotransformations.
• New options in insulin therapy.
• Optimization of the gbeta1 domain by computational design and by in vitro evolution: structural and energetic basis of stabilization.
• Pediatric pet: indications and value of multimodal imaging.
• SNX9 couples actin assembly to phosphoinositide signals and is required for membrane remodeling during endocytosis.
• Screening and purification for novel cytochrome b5 from uncultured environmental micro-organisms.
• Site-directed mutagenesis of loop L3 of sucrose porin ScrY leads to changes in substrate selectivity.
• The dynamin middle domain is critical for tetramerization and higher-order self-assembly.
• [Cardiovascular impact of the autonomic neuropathy of diabetes mellitus]
• [On urinary tract infections after a single catheterization]
• [Suddenly occurring exercise intolerance]